Peptides and methods for the treatment of diabetes
Grant
US12583891B2
Kind: B2
Mar 24, 2026
Assignee
PHOENIX ALPHA
Inventors
Luc Vander Elst, Vincent Carlier, Jean-Marie Saint-Remy
Abstract
The invention relates to peptides such as HCPYCSLQPLALEGSLQKRG [SEQ ID NO: 26] and their use in the treatment of type 1 diabetes and the generation of cytolytic CD4+ T cell.
CPC Classifications
C07K 14/435
A61P 3/10
A61K 35/17
Filing Date
2023-08-08
Application No.
18446172
Claims
11